Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Hyperfine Inc HYPR

Hyperfine, Inc. is a health technology company. The Company provides a Swoop Portable Magnetic Resonance Imaging System (Swoop system), which is a portable magnetic resonance imaging (MRI) system capable of providing neuroimaging at the point of care. Its Swoop system produces images at a lower magnetic field strength than conventional MRI scanners. The Swoop system is a portable, ultra-low... see more

Recent & Breaking News (NDAQ:HYPR)

Hyperfine to Announce Second Quarter 2022 Financial Results on August 10, 2022

GlobeNewswire July 20, 2022

Hyperfine Announces Zero Radiation Dose Rapid MR Imaging Test for Pediatric Hydrocephalus Patients

GlobeNewswire July 14, 2022

Hyperfine Announces CEO Transition

GlobeNewswire June 29, 2022

Hyperfine Announces Expansion into Australia and New Zealand with Medical Device Registration and Notification

GlobeNewswire June 14, 2022

Hyperfine to Present at the 2022 Jefferies Global Healthcare Conference

GlobeNewswire May 25, 2022

Hyperfine Reports First Quarter 2022 Financial Results

GlobeNewswire May 11, 2022

Hyperfine to Announce First Quarter 2022 Financial Results on May 11, 2022

GlobeNewswire April 20, 2022

Hyperfine Reports Fourth Quarter and Full Year 2021 Financial Results

GlobeNewswire March 23, 2022

Hyperfine to Announce Fourth Quarter and Full Year 2021 Financial Results

GlobeNewswire March 3, 2022

Hyperfine to Present at the 42nd Annual Cowen Healthcare Conference

GlobeNewswire March 1, 2022

Queen's University Radiology Receives Hyperfine Portable MRI to Improve Access to Care for Canadian Patients in Remote Northern Communities

GlobeNewswire February 16, 2022

Hyperfine Appoints Chip Truwit, M.D. as Senior Medical Director

GlobeNewswire February 8, 2022

M Health Fairview University of Minnesota Medical Center Receives First Hyperfine Portable MRI to Grow its Advanced Imaging Systems Offering

GlobeNewswire January 19, 2022

Hyperfine Reports Preliminary Unaudited 2021 Revenue and Swoop® System Installations

GlobeNewswire January 10, 2022

Hyperfine to Present at the 40th Annual J.P. Morgan Healthcare Conference

PR Newswire January 4, 2022

Hyperfine Closes Business Combination with HealthCor Catalio Acquisition Corp and Liminal Sciences, Will Begin Trading under the Ticker "HYPR" on the Nasdaq Global Market

PR Newswire December 22, 2021

HealthCor Catalio Acquisition Corp. Reminds Shareholders to Vote in Favor of the Business Combination with Hyperfine, Inc. and Liminal Sciences, Inc.

PR Newswire December 15, 2021

Moore Kuehn Encourages CND, HCAQ, HCCC and FPAC Investors to Contact Law Firm

PR Newswire July 13, 2021

Hyperfine, Inc., Creator of the First FDA-Cleared Portable MRI Device, and Liminal Sciences, Inc. To Be Listed on Nasdaq Through a Business Combination With HealthCor Catalio Acquisition Corp.

Business Wire July 8, 2021

HealthCor Catalio Acquisition Corp. Announces Closing of Upsized $207 Million Initial Public Offering

PR Newswire January 29, 2021